1 Chagas Disease Treatment Market Overview 1.1 Product Overview and Scope of Chagas Disease Treatment 1.2 Chagas Disease Treatment Segment by Type 1.2.1 Global Chagas Disease Treatment Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Benznidazole 1.2.3 Nifurtimox 1.3 Chagas Disease Treatment Segment by Application 1.3.1 Global Chagas Disease Treatment Sales Comparison by Application: (2021-2027) 1.3.2 Hospitals 1.3.3 Retail Pharmacies 1.3.4 Online Pharmacies 1.4 Global Chagas Disease Treatment Market Size Estimates and Forecasts 1.4.1 Global Chagas Disease Treatment Revenue 2016-2027 1.4.2 Global Chagas Disease Treatment Sales 2016-2027 1.4.3 Chagas Disease Treatment Market Size by Region: 2016 Versus 2021 Versus 2027 2 Chagas Disease Treatment Market Competition by Manufacturers 2.1 Global Chagas Disease Treatment Sales Market Share by Manufacturers (2016-2021) 2.2 Global Chagas Disease Treatment Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Chagas Disease Treatment Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Chagas Disease Treatment Manufacturing Sites, Area Served, Product Type 2.5 Chagas Disease Treatment Market Competitive Situation and Trends 2.5.1 Chagas Disease Treatment Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Chagas Disease Treatment Players Market Share by Revenue 2.5.3 Global Chagas Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Chagas Disease Treatment Retrospective Market Scenario by Region 3.1 Global Chagas Disease Treatment Retrospective Market Scenario in Sales by Region: 2016-2021 3.2 Global Chagas Disease Treatment Retrospective Market Scenario in Revenue by Region: 2016-2021 3.3 North America Chagas Disease Treatment Market Facts & Figures by Country 3.3.1 North America Chagas Disease Treatment Sales by Country 3.3.2 North America Chagas Disease Treatment Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Chagas Disease Treatment Market Facts & Figures by Country 3.4.1 Europe Chagas Disease Treatment Sales by Country 3.4.2 Europe Chagas Disease Treatment Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Chagas Disease Treatment Market Facts & Figures by Region 3.5.1 Asia Pacific Chagas Disease Treatment Sales by Region 3.5.2 Asia Pacific Chagas Disease Treatment Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Chagas Disease Treatment Market Facts & Figures by Country 3.6.1 Latin America Chagas Disease Treatment Sales by Country 3.6.2 Latin America Chagas Disease Treatment Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Chagas Disease Treatment Market Facts & Figures by Country 3.7.1 Middle East and Africa Chagas Disease Treatment Sales by Country 3.7.2 Middle East and Africa Chagas Disease Treatment Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Chagas Disease Treatment Historic Market Analysis by Type 4.1 Global Chagas Disease Treatment Sales Market Share by Type (2016-2021) 4.2 Global Chagas Disease Treatment Revenue Market Share by Type (2016-2021) 4.3 Global Chagas Disease Treatment Price by Type (2016-2021) 5 Global Chagas Disease Treatment Historic Market Analysis by Application 5.1 Global Chagas Disease Treatment Sales Market Share by Application (2016-2021) 5.2 Global Chagas Disease Treatment Revenue Market Share by Application (2016-2021) 5.3 Global Chagas Disease Treatment Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Nortec Quimica SA 6.1.1 Nortec Quimica SA Corporation Information 6.1.2 Nortec Quimica SA Description and Business Overview 6.1.3 Nortec Quimica SA Chagas Disease Treatment Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Nortec Quimica SA Chagas Disease Treatment Product Portfolio 6.1.5 Nortec Quimica SA Recent Developments/Updates 6.2 Bayer AG 6.2.1 Bayer AG Corporation Information 6.2.2 Bayer AG Description and Business Overview 6.2.3 Bayer AG Chagas Disease Treatment Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Bayer AG Chagas Disease Treatment Product Portfolio 6.2.5 Bayer AG Recent Developments/Updates 6.3 Laboratorio Elea Phoenix SA 6.3.1 Laboratorio Elea Phoenix SA Corporation Information 6.3.2 Laboratorio Elea Phoenix SA Description and Business Overview 6.3.3 Laboratorio Elea Phoenix SA Chagas Disease Treatment Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Laboratorio Elea Phoenix SA Chagas Disease Treatment Product Portfolio 6.3.5 Laboratorio Elea Phoenix SA Recent Developments/Updates 6.4 Maprimed S.A 6.4.1 Maprimed S.A Corporation Information 6.4.2 Maprimed S.A Description and Business Overview 6.4.3 Maprimed S.A Chagas Disease Treatment Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Maprimed S.A Chagas Disease Treatment Product Portfolio 6.4.5 Maprimed S.A Recent Developments/Updates 6.5 Laboratorio Farmaceutico De Pernambuco 6.5.1 Laboratorio Farmaceutico De Pernambuco Corporation Information 6.5.2 Laboratorio Farmaceutico De Pernambuco Description and Business Overview 6.5.3 Laboratorio Farmaceutico De Pernambuco Chagas Disease Treatment Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Laboratorio Farmaceutico De Pernambuco Chagas Disease Treatment Product Portfolio 6.5.5 Laboratorio Farmaceutico De Pernambuco Recent Developments/Updates 7 Chagas Disease Treatment Manufacturing Cost Analysis 7.1 Chagas Disease Treatment Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Chagas Disease Treatment 7.4 Chagas Disease Treatment Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Chagas Disease Treatment Distributors List 8.3 Chagas Disease Treatment Customers 9 Chagas Disease Treatment Market Dynamics 9.1 Chagas Disease Treatment Industry Trends 9.2 Chagas Disease Treatment Growth Drivers 9.3 Chagas Disease Treatment Market Challenges 9.4 Chagas Disease Treatment Market Restraints 10 Global Market Forecast 10.1 Chagas Disease Treatment Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Chagas Disease Treatment by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Chagas Disease Treatment by Type (2022-2027) 10.2 Chagas Disease Treatment Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Chagas Disease Treatment by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Chagas Disease Treatment by Application (2022-2027) 10.3 Chagas Disease Treatment Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Chagas Disease Treatment by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Chagas Disease Treatment by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Chagas Disease Treatment Sales (K Units) Growth Rate Comparison by Type (2021-2027) Table 2. Global Chagas Disease Treatment Sales (K Units) Comparison by Application (2021-2027) Table 3. Global Chagas Disease Treatment Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Chagas Disease Treatment Covered in This Study Table 5. Global Chagas Disease Treatment Sales (K Units) of Key Manufacturers (2016-2021) Table 6. Global Chagas Disease Treatment Sales Market Share by Manufacturers (2016-2021) Table 7. Global Chagas Disease Treatment Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Chagas Disease Treatment Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Chagas Disease Treatment Average Price (USD/Unit) of Key Manufacturers (2016-2021) Table 10. Manufacturers Chagas Disease Treatment Manufacturing Sites and Area Served Table 11. Manufacturers Chagas Disease Treatment Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Chagas Disease Treatment by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chagas Disease Treatment as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Chagas Disease Treatment Sales by Region (2016-2021) & (K Units) Table 16. Global Chagas Disease Treatment Sales Market Share by Region (2016-2021) Table 17. Global Chagas Disease Treatment Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Chagas Disease Treatment Sales by Country (2016-2021) & (K Units) Table 19. North America Chagas Disease Treatment Sales Market Share by Country (2016-2021) Table 20. North America Chagas Disease Treatment Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Chagas Disease Treatment Revenue Market Share by Country (2016-2021) Table 22. Europe Chagas Disease Treatment Sales by Country (2016-2021) & (K Units) Table 23. Europe Chagas Disease Treatment Sales Market Share by Country (2016-2021) Table 24. Europe Chagas Disease Treatment Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Chagas Disease Treatment Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Chagas Disease Treatment Sales by Region (2016-2021) & (K Units) Table 27. Asia Pacific Chagas Disease Treatment Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Chagas Disease Treatment Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Chagas Disease Treatment Revenue Market Share by Region (2016-2021) Table 30. Latin America Chagas Disease Treatment Sales by Country (2016-2021) & (K Units) Table 31. Latin America Chagas Disease Treatment Sales Market Share by Country (2016-2021) Table 32. Latin America Chagas Disease Treatment Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Chagas Disease Treatment Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Chagas Disease Treatment Sales by Country (2016-2021) & (K Units) Table 35. Middle East and Africa Chagas Disease Treatment Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Chagas Disease Treatment Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Chagas Disease Treatment Revenue Market Share by Country (2016-2021) Table 38. Global Chagas Disease Treatment Sales (K Units) by Type (2016-2021) Table 39. Global Chagas Disease Treatment Sales Market Share by Type (2016-2021) Table 40. Global Chagas Disease Treatment Revenue (Million US$) by Type (2016-2021) Table 41. Global Chagas Disease Treatment Revenue Share by Type (2016-2021) Table 42. Global Chagas Disease Treatment Price (USD/Unit) by Type (2016-2021) Table 43. Global Chagas Disease Treatment Sales (K Units) by Application (2016-2021) Table 44. Global Chagas Disease Treatment Sales Market Share by Application (2016-2021) Table 45. Global Chagas Disease Treatment Revenue (Million US$) by Application (2016-2021) Table 46. Global Chagas Disease Treatment Revenue Share by Application (2016-2021) Table 47. Global Chagas Disease Treatment Price (USD/Unit) by Application (2016-2021) Table 48. Nortec Quimica SA Corporation Information Table 49. Nortec Quimica SA Description and Business Overview Table 50. Nortec Quimica SA Chagas Disease Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 51. Nortec Quimica SA Chagas Disease Treatment Product Table 52. Nortec Quimica SA Recent Developments/Updates Table 53. Bayer AG Corporation Information Table 54. Bayer AG Description and Business Overview Table 55. Bayer AG Chagas Disease Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 56. Bayer AG Chagas Disease Treatment Product Table 57. Bayer AG Recent Developments/Updates Table 58. Laboratorio Elea Phoenix SA Corporation Information Table 59. Laboratorio Elea Phoenix SA Description and Business Overview Table 60. Laboratorio Elea Phoenix SA Chagas Disease Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 61. Laboratorio Elea Phoenix SA Chagas Disease Treatment Product Table 62. Laboratorio Elea Phoenix SA Recent Developments/Updates Table 63. Maprimed S.A Corporation Information Table 64. Maprimed S.A Description and Business Overview Table 65. Maprimed S.A Chagas Disease Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 66. Maprimed S.A Chagas Disease Treatment Product Table 67. Maprimed S.A Recent Developments/Updates Table 68. Laboratorio Farmaceutico De Pernambuco Corporation Information Table 69. Laboratorio Farmaceutico De Pernambuco Description and Business Overview Table 70. Laboratorio Farmaceutico De Pernambuco Chagas Disease Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021) Table 71. Laboratorio Farmaceutico De Pernambuco Chagas Disease Treatment Product Table 72. Laboratorio Farmaceutico De Pernambuco Recent Developments/Updates Table 73. Production Base and Market Concentration Rate of Raw Material Table 74. Key Suppliers of Raw Materials Table 75. Chagas Disease Treatment Distributors List Table 76. Chagas Disease Treatment Customers List Table 77. Chagas Disease Treatment Market Trends Table 78. Chagas Disease Treatment Growth Drivers Table 79. Chagas Disease Treatment Market Challenges Table 80. Chagas Disease Treatment Market Restraints Table 81. Global Chagas Disease Treatment Sales Forecast by Type (2022-2027) & (K Units) Table 82. Global Chagas Disease Treatment Sales Market Share Forecast by Type (2022-2027) Table 83. Global Chagas Disease Treatment Revenue Forecast by Type (2022-2027) & (US$ Million) Table 84. Global Chagas Disease Treatment Revenue Market Share Forecast by Type (2022-2027) Table 85. Global Chagas Disease Treatment Sales Forecast by Application (2022-2027) & (K Units) Table 86. Global Chagas Disease Treatment Sales Market Share Forecast by Application (2022-2027) Table 87. Global Chagas Disease Treatment Revenue Forecast by Application (2022-2027) & (US$ Million) Table 88. Global Chagas Disease Treatment Revenue Market Share Forecast by Application (2022-2027) Table 89. Global Chagas Disease Treatment Sales Forecast by Region (2022-2027) & (K Units) Table 90. Global Chagas Disease Treatment Sales Market Share Forecast by Region (2022-2027) Table 91. Global Chagas Disease Treatment Revenue Forecast by Region (2022-2027) & (US$ Million) Table 92. Global Chagas Disease Treatment Revenue Market Share Forecast by Region (2022-2027) Table 93. Research Programs/Design for This Report Table 94. Key Data Information from Secondary Sources Table 95. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Chagas Disease Treatment Figure 2. Global Chagas Disease Treatment Market Share by Type in 2020 & 2027 Figure 3. Benznidazole Product Picture Figure 4. Nifurtimox Product Picture Figure 5. Global Chagas Disease Treatment Market Share by Application in 2020 & 2027 Figure 6. Hospitals Figure 7. Retail Pharmacies Figure 8. Online Pharmacies Figure 9. Global Chagas Disease Treatment Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 10. Global Chagas Disease Treatment Market Size 2016-2027 (US$ Million) Figure 11. Global Chagas Disease Treatment Sales 2016-2027 (K Units) Figure 12. Global Chagas Disease Treatment Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 13. Chagas Disease Treatment Sales Share by Manufacturers in 2020 Figure 14. Global Chagas Disease Treatment Revenue Share by Manufacturers in 2020 Figure 15. The Global 5 and 10 Largest Chagas Disease Treatment Players: Market Share by Revenue in 2020 Figure 16. Chagas Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 17. Global Chagas Disease Treatment Sales Market Share by Region (2016-2021) Figure 18. Global Chagas Disease Treatment Sales Market Share by Region in 2020 Figure 19. Global Chagas Disease Treatment Revenue Market Share by Region (2016-2021) Figure 20. Global Chagas Disease Treatment Revenue Market Share by Region in 2020 Figure 21. U.S. Chagas Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 22. Canada Chagas Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 23. Germany Chagas Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. France Chagas Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. U.K. Chagas Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. Italy Chagas Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. Russia Chagas Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. China Chagas Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. Japan Chagas Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. South Korea Chagas Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. India Chagas Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. Australia Chagas Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Taiwan Chagas Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Indonesia Chagas Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Thailand Chagas Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Malaysia Chagas Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Philippines Chagas Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Vietnam Chagas Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Mexico Chagas Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Brazil Chagas Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Argentina Chagas Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Turkey Chagas Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Saudi Arabia Chagas Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. U.A.E Chagas Disease Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Sales Market Share of Chagas Disease Treatment by Type (2016-2021) Figure 46. Sales Market Share of Chagas Disease Treatment by Application (2016-2021) Figure 47. Sales Market Share of Chagas Disease Treatment by Application in 2020 Figure 48. Revenue Share of Chagas Disease Treatment by Application (2016-2021) Figure 49. Revenue Share of Chagas Disease Treatment by Application in 2020 Figure 50. Manufacturing Cost Structure of Chagas Disease Treatment Figure 51. Manufacturing Process Analysis of Chagas Disease Treatment Figure 52. Chagas Disease Treatment Industrial Chain Analysis Figure 53. Channels of Distribution Figure 54. Distributors Profiles Figure 55. Bottom-up and Top-down Approaches for This Report Figure 56. Data Triangulation Figure 57. Key Executives Interviewed

Nortec Quimica SA Bayer AG Laboratorio Elea Phoenix SA Maprimed S.A Laboratorio Farmaceutico De Pernambuco